As the dimeric RevTM CEA-IgG4-7B6 has two RevCAR binding arms, it bears the possibility to activate RevCAR T-cells by cross-linking two RevCARs in the absence of target-expressing tumor cells similar to the CAR signaling effect observed for other bivalent soluble molecules (62). This evidence concerns the gene CEACAM5 and neoplasm.